Skip to main content

Table 2 RTOG skin toxicities in both groups [n (%)]

From: A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy

Group

Grade 1

Grade 2

Grade 3

Control intervention (n = 49)

16(32.7)

23(46.9)

10(20.4)

Sanyrene (n = 50)

39(78.0)

7(14.0)

4(8.0)

p

< 0.001

< 0.001

0.076

  1. RTOG, Radiation Therapy Oncology Group
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us